{"eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":10,"description":"Patients with hyperprolactinemia were treated with long-term ROP therapy for 6 months in an open-label dose escalation study\n\nRopinirole: 0.25mg/day - 6.0mg/day oral non-ergoline dopamine agonist ropinirole","id":"EG000","otherNumAffected":8,"otherNumAtRisk":10,"seriousNumAffected":0,"seriousNumAtRisk":10,"title":"ROP Intervention"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":10}],"term":"Fatigue"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":10}],"term":"Nausea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":10}],"term":"Headache"}],"timeFrame":"6 months"}